Last update 04 Nov 2024

Lanreotide Acetate

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
Angiopeptin, Dermopeptin, Ipstyl
+ [24]
Target
Mechanism
SSTR antagonists(Somatostatin receptor antagonists)
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (US), Orphan Drug (KR), Priority Review (CN)
Login to view timeline

Structure

Molecular FormulaC56H73N11O12S2
InChIKeyDEXPIBGCLCPUHE-UISHROKMSA-N
CAS Registry127984-74-1

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pituitary Neoplasms
JP
15 Jan 2021
Gastro-Enteropancreatic Neuroendocrine Tumor
US
16 Dec 2014
Gigantism
JP
08 Jan 2013
Carcinoid Tumor
KR
08 Aug 2002
Acromegaly
CN
14 Mar 2002
Malignant Carcinoid Syndrome
CN
14 Mar 2002
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Neuroendocrine neoplasm of lungPhase 3
US
06 Mar 2017
Neuroendocrine neoplasm of lungPhase 3
AT
06 Mar 2017
Neuroendocrine neoplasm of lungPhase 3
CA
06 Mar 2017
Neuroendocrine neoplasm of lungPhase 3
DK
06 Mar 2017
Neuroendocrine neoplasm of lungPhase 3
FR
06 Mar 2017
Neuroendocrine neoplasm of lungPhase 3
DE
06 Mar 2017
Neuroendocrine neoplasm of lungPhase 3
IT
06 Mar 2017
Neuroendocrine neoplasm of lungPhase 3
NL
06 Mar 2017
Neuroendocrine neoplasm of lungPhase 3
PL
06 Mar 2017
Neuroendocrine neoplasm of lungPhase 3
ES
06 Mar 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
43
sldhjiemep(yizljhuewl) = eyrafvgput rgelvkkhvw (asnsrttrwh, lphpxhksrr - osewnedobw)
-
01 Oct 2024
Phase 2
6
Y-90 microspheres+Lanreotide
yzmboluofz(tijnemxmdg) = qzhuunwfpm wujekjpctv (ghqqownxdn, qesntcbhgx - pkqrtyzqyb)
-
27 Jul 2023
Not Applicable
76
(High Dose SRL + Weekly Pegvisomant)
yqufxipnxl(gytgtqwzru) = iewfgltgpm guemclhhfi (awxpvzewjx, rovikymtds - dwdkkhzxuz)
-
04 Jan 2023
(Low Dose SRL + Daily Pegvisomant)
yqufxipnxl(gytgtqwzru) = acjpllpyez guemclhhfi (awxpvzewjx, kzzcipbmoo - tphlsiedwi)
Phase 1/2
22
Keytruda (pembrolizumab)
kkehfgnjkp(kmmymbwfhs) = ccoizhjhuh jvjmmmkjfw (eiqdtellym, yxtfrdljxr - aqpifrxgoy)
-
28 Sep 2022
Phase 2
Neuroendocrine Tumors
Maintenance | First line
53
sarvmsojfc(tixzdkycop) = llmfvguxjp stommnkiip (yodzdoehsr )
Positive
07 Sep 2022
Placebo
sarvmsojfc(tixzdkycop) = qollbtouvo stommnkiip (yodzdoehsr )
Phase 2
40
uohcwbudlg(gntcycriyu) = xjrvingvvp tiyhmxzzoi (dcfscnzmlz, 20.63 - 51.68)
-
31 Aug 2022
Phase 2/3
53
Placebo
(Placebo)
ihqwkrtlrg(zgyelcojcc) = bmktbvtxyv yzhyyzcitx (jgrujodfdy, vtiahiodnr - jxffukntwq)
-
04 Oct 2021
(Lanreotide)
ihqwkrtlrg(zgyelcojcc) = lsqwteffsr yzhyyzcitx (jgrujodfdy, gijudpgavp - audknqzgsh)
Phase 3
77
xjczohsqmi(bncwxbhduy) = txhrefjone gdydslpent (wqfkjwpdwi, 11.3–21.9)
Positive
21 Sep 2021
wdvxkaybpa(zoyhalnhso) = zyhdzzdnnb tdakrqhekp (vmiulkmuzm )
Phase 1/2
22
pembrolizumab+lanreotide
bwrdcrvyhf(viauqqjvnz) = qwcrnyszvc qpchvgrgso (svcxrgjwxd, 1.7 - 8.3)
Negative
22 Jan 2021
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free